Earnings · China A-shares
Lanzhou Foci Pharmaceutical Co., Ltd. Class A (002644) earnings
Lanzhou Foci Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit +33.19% year on year, +60.88% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +0.54% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- +33.19%
- Excl. one-offs YoY
- +60.88%
- Net profit QoQ
- -35.69%
- Result
- Good
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.40% | — |
| 3 days | +0.54% | — |
| 7 days | +2.15% | — |
| 14 days | -1.34% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 4 of 7 reports (average -0.66%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥50.72M | +33.19% | +60.88% | +4.19% | 0.10 | 2.73% | +0.54% | — | — |
| 2026 interim report | 2026-08-20 | ¥39.74M | +32.00% | +48.72% | +2.55% | 0.08 | 2.15% | +0.00% | +0.12% | +5.81% |
| 2026 Q1 report | 2026-04-30 | ¥22.66M | +16.92% | +25.83% | -2.11% | 0.04 | 1.23% | +1.46% | -7.91% | -9.96% |
| 2025 annual report | 2026-04-09 | ¥49.21M | -18.08% | -37.54% | -6.60% | 0.10 | 2.71% | -4.37% | -14.46% | -21.65% |
| 2025 Q3 report | 2025-10-29 | ¥38.08M | -2.54% | -5.45% | -11.92% | 0.07 | 2.00% | +0.22% | -2.89% | +0.58% |
| 2025 interim report | 2025-08-27 | ¥30.10M | -16.60% | -24.91% | -13.93% | 0.06 | 1.67% | -2.99% | -5.76% | -9.53% |
| 2025 Q1 report | 2025-04-26 | ¥19.38M | +5.41% | -0.48% | -21.22% | 0.04 | 1.08% | +0.52% | +12.90% | +9.66% |
| 2024 annual report | 2025-04-26 | ¥60.07M | -10.60% | -36.38% | -15.73% | 0.12 | 3.38% | +0.52% | +12.90% | +9.66% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.